Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 21-Feb 2018. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 77265501000001116 | Fluticasone + Vilanterol (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 77265601000001117 | Fluticasone + Vilanterol | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Fluticasone + Vilanterol | Is a | Product containing fluticasone | false | Inferred relationship | Existential restriction modifier | ||
| Fluticasone + Vilanterol | Is a | Product containing beta-2 adrenergic receptor agonist | false | Inferred relationship | Existential restriction modifier | ||
| Fluticasone + Vilanterol | Is a | Virtual therapeutic moiety | false | Inferred relationship | Existential restriction modifier | ||
| Fluticasone + Vilanterol | Has active ingredient | Fluticasone | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Fluticasone furoate 184micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler | Is a | False | Fluticasone + Vilanterol | Inferred relationship | Existential restriction modifier | |
| Fluticasone furoate 92micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler | Is a | False | Fluticasone + Vilanterol | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR